Maternal and fetal side effects of tocolysis using transdermal nitroglycerin or intravenous fenoterol combined with magnesium sulfate.

Author: GrossWalter, KählerChristiane, MöllerArne, MöllerUdo, RichterSabine, SchleussnerEkkehard, SeewaldHans Joachim

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To compare the maternal and fetal side effects of transdermal nitroglycerin and intravenous fenoterol combined with magnesium sulfate in a prospective randomised study. STUDY DESIGN: Fifty pregnant women between 27 and 35 weeks of gestation with preterm labour were treated with either ni...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/s0301-2115(02)00197-5

データ提供:米国国立医学図書館(NLM)

Comparing Tocolysis Methods for Preterm Labor

This research delves into the intricate world of obstetrics, specifically focusing on preterm labor. The study uses a randomized controlled trial design, a gold standard in research, to compare two tocolytic therapies: transdermal nitroglycerin and intravenous fenoterol combined with magnesium sulfate. The researchers carefully analyzed the maternal and fetal side effects associated with each therapy, aiming to identify a safer and more effective treatment option for preterm labor.

Transdermal Nitroglycerin: A Promising Tocolytic Therapy

The study found that transdermal nitroglycerin appears to be a safer option for both mother and fetus compared to intravenous fenoterol. The researchers observed fewer maternal side effects in the nitroglycerin group, with headaches being the most common adverse effect. In contrast, the fenoterol group experienced more palpitations, tremors, and restlessness. These findings suggest that transdermal nitroglycerin could be a promising new treatment for preterm labor.

Navigating Preterm Labor with Confidence

This research provides valuable information for expectant mothers facing preterm labor. It emphasizes the importance of considering potential side effects associated with different tocolytic therapies and highlights the potential benefits of transdermal nitroglycerin. By understanding the nuances of these treatments, both mothers and healthcare providers can make informed decisions and navigate the complexities of preterm labor with greater confidence.

Dr.Camel's Conclusion

This research represents a significant stride in the field of obstetrics, offering a safer and potentially more effective treatment option for preterm labor. By harnessing the power of evidence-based research, we can continue to improve the well-being of mothers and babies facing the challenges of preterm birth, just like a caravan carefully navigating the treacherous dunes of the desert.

Date :
  1. Date Completed 2003-09-23
  2. Date Revised 2019-08-16
Further Info :

Pubmed ID

12475575

DOI: Digital Object Identifier

10.1016/s0301-2115(02)00197-5

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.